Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Earnings for Virbac SA (VIRP.PA)
Earnings in 2023 (TTM): $168.84 M
According to Virbac SA's latest financial reports the company's current earnings (TTM) are $168.84 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Virbac SA
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $168.84 M | $127.96 M |
| 2022 | $175.16 M | $128.66 M |
| 2021 | $158.38 M | $119.38 M |
| 2020 | $182.84 M | $143.51 M |
| 2019 | $82.14 M | $54.38 M |
| 2018 | $43.62 M | $21.2 M |
| 2017 | $43.25 M | $-2,716,395 |
| 2016 | $55.76 M | $36.55 M |
| 2015 | $15.41 M | $9.92 M |
| 2014 | $105.15 M | $67.09 M |
| 2013 | $99.94 M | $63.85 M |
| 2012 | $100.7 M | $70.28 M |
| 2011 | $88.09 M | $61.77 M |
| 2010 | $90.86 M | $67.84 M |
| 2009 | $59.46 M | $41.85 M |
| 2008 | $53.16 M | $38.28 M |
| 2007 | $50.88 M | $33.62 M |
| 2006 | $39.9 M | $26.28 M |
| 2005 | $32.25 M | $20.89 M |
| 2004 | $26.67 M | $17.64 M |
| 2003 | $ | $29.06 M |
| 2002 | $ | $41.97 M |